Home › Companies › AbbVie Inc. › 2025-2026

AbbVie Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and AbbVie Inc.’s Form 8-K, filed May 12, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

  • 8Ballot items
  • 1,729Asset managers
  • 15,779Fund votes
  • May 8, 2026Meeting date

Results at a glance

Meeting of May 8, 2026: 8 items on AbbVie Inc.’s Form 8-K, filed May 12, 2026: 2 approved · 2 not approved · 4 without a stated outcome.

Not approved or not elected

Material dissent

None beyond the items above.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AbbVie Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by AbbVie Inc.

These tallies are AbbVie Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AbbVie Inc. — official shareholder meeting results, meeting held May 8, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Jennifer L. Davis 1,216,558,75489,839,3292,680,369 --239,399,581 93%Not verified—
Elect Director: Melody B. Meyer 1,284,771,57822,470,0741,836,800 --239,399,581 98%Not verified—
Elect Director: Robert A. Michael 1,221,224,37085,865,8521,988,230 --239,399,581 93%Not verified—
Elect Director: Frederick H. Waddell 1,225,237,82581,747,0332,093,594 --239,399,581 94%Not verified—
2. The appointment of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 1,522,575,01223,766,5642,136,457 ---- 98%Approved—
3. The compensation of AbbVie's named executive officers 1,228,615,74569,336,35911,126,348 --239,399,581 95%Approved—
4. The management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting 1,290,990,02314,896,1193,192,310 --239,399,581 99%Not approved
Not approved: the filing states that this item needed more than a majority of the votes cast.
—
5. A stockholder proposal to adopt a policy to require an independent chair 515,626,009787,253,9706,198,473 --239,399,581 40%Not approved—

Source: AbbVie Inc., Form 8-K, filed with the SEC on May 12, 2026 — read the filing on EDGAR.

How asset managers voted at the AbbVie Inc. 2025-2026 meeting

Each item below shows how the 1,729 asset managers that disclosed a AbbVie Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Jennifer L. Davis

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 9 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 1,216,558,754AGAINST: 89,839,329
Details: description as filed, official tally, votes by 275 asset managers

Description as filed by funds: Election of Class II Directors: Jennifer L. Davis

AbbVie Inc.’s own tally for this item (“Elect Director: Jennifer L. Davis”): 1,216,558,754 for, 89,839,329 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 275 asset managers below reported 495,647,281 for, 10,622,150 against, 84,467 abstained, 1,342 not voted, 81,392 unknown.

FOR
FOR: 495,647,281AGAINST: 10,622,150ABSTAIN: 84,467UNKNOWN: 81,392NOT VOTED: 1,342
Largest asset managers voting on “Election of Class II Directors: Jennifer L. Davis” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard168,617,8281,083 440For
Fidelity57,643,205573,691 00For
BlackRock55,981,9040 00For
Capital Group48,531,3830 00For
Charles Schwab24,144,5560 00For
State Street21,332,9130 00For
JPMorgan19,167,9040 00For
TIAA9,206,6660 00For
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price5,5416,782,949 00Against
Columbia Threadneedle6,281,5890 00For
Invesco5,225,2170 00For
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS3,857,5640 00For
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO2,728,2080 00For
Dimensional2,654,7060 00For
Federated Hermes2,542,9590 00For
Prudential/PGIM2,161,4170 00For
WisdomTree2,158,3700 00For
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock1,141,016933,978 00Mixed
Jackson National2,001,3602,108 00For
American Century1,941,7830 00For

Showing the 25 largest of 275 asset managers. See all 275 in the interactive database.

2. Elect Director: Melody B. Meyer

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 8 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 1,284,771,578AGAINST: 22,470,074
Details: description as filed, official tally, votes by 275 asset managers

Description as filed by funds: Election of Class II Directors: Melody B. Meyer

AbbVie Inc.’s own tally for this item (“Elect Director: Melody B. Meyer”): 1,284,771,578 for, 22,470,074 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 275 asset managers below reported 497,681,891 for, 8,587,555 against, 84,452 abstained, 1,342 not voted, 81,392 unknown.

FOR
FOR: 497,681,891AGAINST: 8,587,555ABSTAIN: 84,452UNKNOWN: 81,392NOT VOTED: 1,342
Largest asset managers voting on “Election of Class II Directors: Melody B. Meyer” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard168,618,576350 290For
Fidelity57,643,205573,691 00For
BlackRock55,981,9040 00For
Capital Group48,531,3830 00For
Charles Schwab24,144,5560 00For
State Street21,332,9130 00For
JPMorgan19,167,9040 00For
TIAA9,206,6660 00For
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price5,5416,782,949 00Against
Columbia Threadneedle6,281,5890 00For
Invesco5,225,2170 00For
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS3,857,5640 00For
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO2,728,2080 00For
Dimensional2,654,7060 00For
Federated Hermes2,542,9590 00For
Prudential/PGIM2,161,4170 00For
WisdomTree2,158,3700 00For
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock1,141,016933,978 00Mixed
Jackson National2,001,3602,108 00For
American Century1,941,7830 00For

Showing the 25 largest of 275 asset managers. See all 275 in the interactive database.

3. Elect Director: Robert A. Michael

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 9 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 1,221,224,370AGAINST: 85,865,852
Details: description as filed, official tally, votes by 275 asset managers

Description as filed by funds: Election of Class II Directors: Robert A. Michael

AbbVie Inc.’s own tally for this item (“Elect Director: Robert A. Michael”): 1,221,224,370 for, 85,865,852 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 275 asset managers below reported 504,577,470 for, 1,691,975 against, 84,455 abstained, 1,342 not voted, 81,392 unknown.

FOR
FOR: 504,577,470AGAINST: 1,691,975ABSTAIN: 84,455UNKNOWN: 81,392NOT VOTED: 1,342
Largest asset managers voting on “Election of Class II Directors: Robert A. Michael” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard168,617,6461,279 320For
Fidelity58,216,8960 00For
BlackRock55,981,9040 00For
Capital Group48,531,3830 00For
Charles Schwab24,144,5560 00For
State Street21,332,723190 00For
JPMorgan19,167,9040 00For
TIAA9,206,6660 00For
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price6,788,4900 00For
Columbia Threadneedle6,281,5890 00For
Invesco5,225,2170 00For
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS3,857,5640 00For
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO2,728,2080 00For
Dimensional2,654,7060 00For
Federated Hermes2,542,9590 00For
Prudential/PGIM2,161,4170 00For
WisdomTree2,158,3700 00For
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock1,172,344902,650 00Mixed
Jackson National2,003,4680 00For
American Century1,941,7830 00For

Showing the 25 largest of 275 asset managers. See all 275 in the interactive database.

4. Elect Director: Frederick H. Waddell

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 9 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 1,225,237,825AGAINST: 81,747,033
Details: description as filed, official tally, votes by 275 asset managers

Description as filed by funds: Election of Class II Directors: Frederick H. Waddell

AbbVie Inc.’s own tally for this item (“Elect Director: Frederick H. Waddell”): 1,225,237,825 for, 81,747,033 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 275 asset managers below reported 496,759,656 for, 9,509,784 against, 84,456 abstained, 1,342 not voted, 81,392 unknown.

FOR
FOR: 496,759,656AGAINST: 9,509,784ABSTAIN: 84,456UNKNOWN: 81,392NOT VOTED: 1,342
Largest asset managers voting on “Election of Class II Directors: Frederick H. Waddell” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard168,617,6781,241 330For
Fidelity57,643,205573,691 00For
BlackRock55,981,9040 00For
Capital Group48,531,3830 00For
Charles Schwab24,144,5560 00For
State Street21,332,566347 00For
JPMorgan19,167,9040 00For
TIAA9,206,6660 00For
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price5,5416,782,949 00Against
Columbia Threadneedle6,281,5890 00For
Invesco5,225,2170 00For
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS3,857,5640 00For
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO2,728,2080 00For
Dimensional2,654,7060 00For
Federated Hermes2,542,9590 00For
Prudential/PGIM2,161,4170 00For
WisdomTree2,158,3700 00For
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock1,141,016933,978 00Mixed
Jackson National2,001,3602,108 00For
American Century1,941,7830 00For

Showing the 25 largest of 275 asset managers. See all 275 in the interactive database.

5. 4. The management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting

Official resultCORPORATE GOVERNANCEReported outcome: Not approved

Combines 9 wordings of this item as funds reported it.

99% Not approved · of votes cast

FOR 99%
FOR: 1,290,990,023AGAINST: 14,896,119
Details: description as filed, official tally, votes by 277 asset managers

Description as filed by funds: Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting

AbbVie Inc.’s own tally for this item (“4. The management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting”): 1,290,990,023 for, 14,896,119 against — failed, per its Form 8-K filed May 12, 2026 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.

Reported outcome: Not approved, in the filing’s own words: “(4) The stockholders did not approve the management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting, as follows:”
Not approved: the filing states that this item needed more than a majority of the votes cast.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AbbVie Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Eliminate Supermajority Vote Requirement” (9 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 277 asset managers below reported 506,001,558 for, 25,238 against, 47 abstained, 1,342 not voted, 10,390 unknown.

FOR
FOR: 506,001,558AGAINST: 25,238ABSTAIN: 47UNKNOWN: 10,390NOT VOTED: 1,342
Largest asset managers voting on “Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate superma” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard168,618,669238 470For
Fidelity58,216,8960 00For
BlackRock55,981,9040 00For
Capital Group48,531,3830 00For
Charles Schwab24,144,5560 00For
State Street21,332,9130 00For
JPMorgan19,167,9040 00For
TIAA9,206,6660 00For
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price6,788,4900 00For
Columbia Threadneedle6,281,5890 00For
Invesco5,225,2170 00For
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS3,857,5640 00For
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO2,728,2080 00For
Dimensional2,654,7060 00For
Federated Hermes2,542,9590 00For
Prudential/PGIM2,161,4170 00For
WisdomTree2,158,3700 00For
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock2,074,9940 00For
Jackson National2,003,4680 00For
American Century1,941,7830 00For

Showing the 25 largest of 277 asset managers. See all 277 in the interactive database.

6. 3. The compensation of AbbVie's named executive officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 1,228,615,745AGAINST: 69,336,359
Details: description as filed, official tally, votes by 1,595 asset managers

Description as filed by funds: Say on Pay - An advisory vote on the approval of executive compensation

AbbVie Inc.’s own tally for this item (“3. The compensation of AbbVie's named executive officers”): 1,228,615,745 for, 69,336,359 against — passed, per its Form 8-K filed May 12, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(3) The stockholders approved, on an advisory basis, the compensation of AbbVie's named executive officers, as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of AbbVie Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (135 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “SAY ON PAY” (7 managers, 557,594 for); “Say on Pay - An advisory vote on the approval of executive H” (3 managers, 18,297 for); “Say on Pay - An advisory vote on the approval of executive compensation More Details” (3 managers, 29,600 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 249 asset managers voting on “Say on Pay - An advisory vote on the approval of executive compensation” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard168,617,861914 1810For
Fidelity58,216,8960 00For
BlackRock55,981,9040 00For
Capital Group48,531,3830 00For
Charles Schwab24,144,5560 00For
State Street21,332,566347 00For
JPMorgan19,167,9040 00For
TIAA9,206,6660 00For
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price6,788,4900 00For
Columbia Threadneedle6,281,5890 00For
Invesco5,225,2170 00For
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS3,857,5640 00For
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO2,728,2080 00For
Dimensional2,654,7060 00For
Federated Hermes2,542,9590 00For
Prudential/PGIM2,161,4170 00For
WisdomTree2,158,3700 00For
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock2,074,9940 00For
Jackson National2,003,4680 00For
American Century1,941,7830 00For

Fund voting reports, all 249 managers: 503,087,724 for, 1,808,559 against, 1,201,192 abstained, 1,343 not voted, 10,390 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1,390 asset managers voting on “Say on Pay - An advisory vote on the approval of executive compensation” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock72,418,8668,236 00For
GEODE CAPITAL MANAGEMENT, LLC46,449,1840 00For
Capital Research Global Investors30,971,7150 00For
State Street29,595,168529,093 00For
Capital Group27,875,0830 3,8240For
Charles Schwab26,006,5470 00For
Fidelity19,459,0940 00For
Vanguard18,753,0740 00For
Northern Trust18,082,428156,789 00For
T. Rowe Price15,470,98150,230 00For
UBS13,135,171979,746 00Mixed
Janus Henderson12,778,16019,172 00For
Amundi11,778,644104,967 00For
Nuveen10,301,425329 00For
Invesco9,727,59213 20For
MELLON INVESTMENTS Corp8,712,5790 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC8,631,7420 00For
Fisher Asset Management, LLC8,246,0540 00For
Goldman Sachs7,981,8070 00For
Wellington7,970,2660 00For
Legal & General Investment Management Ltd184,2687,579,293 00Against
Putnam7,001,3180 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/6,843,1620 00For
FRANKLIN ADVISERS INC6,695,2760 00For
National Pension Service5,274,5630 00For

Institutional-manager reports, all 1,390 managers: 674,973,215 for, 33,942,029 against, 1,462 withheld, 4,455,623 abstained, 379,564 not voted, 71,002 unknown. Showing the 25 largest; see all in the interactive database.

7. 2. The appointment of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 1,522,575,012AGAINST: 23,766,564
Details: description as filed, official tally, votes by 281 asset managers

Description as filed by funds: Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026

AbbVie Inc.’s own tally for this item (“2. The appointment of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026”): 1,522,575,012 for, 23,766,564 against — passed, per its Form 8-K filed May 12, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “(2) The stockholders ratified the appointment of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 281 asset managers below reported 506,600,514 for, 18,993 against, 84,446 abstained, 1,342 not voted, 81,392 unknown.

FOR
FOR: 506,600,514AGAINST: 18,993ABSTAIN: 84,446UNKNOWN: 81,392NOT VOTED: 1,342
Largest asset managers voting on “Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard168,618,587344 230For
Fidelity58,216,8960 00For
BlackRock55,981,9040 00For
Capital Group48,531,3830 00For
Charles Schwab24,144,5560 00For
State Street21,332,566347 00For
JPMorgan19,167,9040 00For
TIAA9,206,6660 00For
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price6,788,4900 00For
Columbia Threadneedle6,281,5890 00For
Invesco5,225,2170 00For
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS3,857,5640 00For
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO2,728,2080 00For
Dimensional2,654,7060 00For
Federated Hermes2,542,9590 00For
Prudential/PGIM2,161,4170 00For
WisdomTree2,158,3700 00For
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock2,074,9940 00For
Jackson National2,003,4680 00For
American Century1,941,7830 00For

Showing the 25 largest of 281 asset managers. See all 281 in the interactive database.

8. 5. A stockholder proposal to adopt a policy to require an independent chair

Official resultCORPORATE GOVERNANCEReported outcome: Not approved

Combines 5 wordings of this item as funds reported it.

40% Not approved · of votes cast

FOR 40%AGAINST
FOR: 515,626,009AGAINST: 787,253,970
Details: description as filed, official tally, votes by 277 asset managers

Description as filed by funds: Stockholder Proposal - to Adopt a Policy to Require an Independent Chair

AbbVie Inc.’s own tally for this item (“5. A stockholder proposal to adopt a policy to require an independent chair”): 515,626,009 for, 787,253,970 against — failed, per its Form 8-K filed May 12, 2026 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “(5) The stockholders did not approve a stockholder proposal to adopt a policy to require an independent chair, as follows:”
Support: 40% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 277 asset managers below reported 113,221,653 for, 393,120,706 against, 84,518 abstained, 1,342 not voted, 12,442 unknown.

FORAGAINST
FOR: 113,221,653AGAINST: 393,120,706ABSTAIN: 84,518UNKNOWN: 12,442NOT VOTED: 1,342
Largest asset managers voting on “Stockholder Proposal - to Adopt a Policy to Require an Independent Chair” at AbbVie Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,633,619163,985,239 950Against
Fidelity241,45157,975,445 00Against
BlackRock63,43055,918,474 00Against
Capital Group48,531,3830 00For
Charles Schwab3,01424,141,542 00Against
State Street10,18221,322,731 00Against
JPMorgan019,167,904 00Against
TIAA09,206,666 00Against
INVESTMENT CO OF AMERICA8,308,7520 00For
T. Rowe Price06,788,490 00Against
Columbia Threadneedle6,281,5890 00For
Invesco3,287,4831,937,734 00Mixed
Putnam4,765,8800 00For
JANUS INVESTMENT FUND4,246,9060 00For
MFS03,857,564 00Against
Franklin Custodian Funds3,412,1890 00For
MASTER INVESTMENT PORTFOLIO02,728,208 00Against
Dimensional02,654,706 00Against
Federated Hermes2,542,9590 00For
Prudential/PGIM2,129,36432,053 00For
WisdomTree02,158,370 00Against
FRANKLIN MANAGED TRUST2,105,0000 00For
John Hancock2,022,90352,091 00For
Jackson National102,2111,901,257 00Mixed
American Century01,941,783 00Against

Showing the 25 largest of 277 asset managers. See all 277 in the interactive database.

Not shown here: this season’s fund filings also report 1 item from the meeting of May 9, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest AbbVie Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,766,792,821 shares outstanding at the time of that meeting.

Fund voting reports: top AbbVie Inc. shareholders by shares voted on “Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 9.54%
2Fidelity 3.30%
3BlackRock 3.17%
4Capital Group 2.75%
5Charles Schwab 1.37%
6State Street 1.21%
7JPMorgan 1.08%
8TIAA 0.52%
9INVESTMENT CO OF AMERICA 0.47%
10T. Rowe Price 0.38%
Institutional-manager reports: top AbbVie Inc. shareholders by shares voted on “Say on Pay - An advisory vote on the approval of executive compensation”, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 4.10%
2GEODE CAPITAL MANAGEMENT, LLC 2.63%
3Capital Research Global Investors 1.75%
4State Street 1.71%
5Capital Group 1.58%
6Charles Schwab 1.47%
7Fidelity 1.10%
8Vanguard 1.06%
9Northern Trust 1.03%
10T. Rowe Price 0.88%

Reported AbbVie Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

AbbVie Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Vanguard Group 10.23% 13F
BlackRock 8.53% 13F
State Street 4.60% 13F
JPMorgan Chase 3.21% 13F
Morgan Stanley 2.27% 13F
FMR (Fidelity) 1.23% 13F
Northern Trust 1.20% 13F
Goldman Sachs 0.93% 13F
Franklin Templeton 0.82% 13F

Percentages above are of 1,766,792,821 shares outstanding, as reported by AbbVie Inc. on its Form 10-Q dated April 28, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AbbVie Inc.’s 10-Q dated April 28, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At AbbVie Inc.'s shareholder meeting held May 8, 2026, in the 2025-2026 proxy season, 1,729 asset managers reported how they voted on 8 ballot items in their SEC Form N-PX filings, covering 15,779 separate fund positions. On the most widely held item on that ballot — Say on Pay - An advisory vote on the approval of executive compensation — AbbVie Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AbbVie Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 12, 2026.

AbbVie Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.